Oncology networks and clinical care pathways in contemporary surgical oncology: between appropriateness, governance, and the sustainability of clinical practice

Background: Technological innovation is transforming endocrine surgery through new diagnostic and therapeutic tools that enhance precision, safety, and personalization of care. However, their clinical value depends on appropriate integration into evidence-based care pathways. This review summarizes the scientific discussions presented during the session “Innovations in Endocrine Surgery” at the 44th National Congress of the Italian Association of Hospital Surgeons, Palermo, Italy, 24–27 May 2026. Methods: A narrative review was conducted of presentations addressing ultrasound-guided thermal ablation, intraoperative neuromonitoring, lymphadenectomy in differentiated thyroid carcinoma, anaplastic thyroid carcinoma, intraoperative parathyroid identification, robotic and remote-access thyroid surgery, and laparoscopic versus robotic adrenalectomy. Session transcripts were analyzed according to the methodology described by Molteni et al. Findings were critically interpreted using current international guidelines and primary literature. Results: A consistent message emerged across all topics. Thermal ablation, near-infrared autofluorescence, neuromonitoring, and robotic platforms expand the technical possibilities of endocrine surgery by improving precision, safety, ergonomics, and, in selected patients, quality of life. However, their benefits consistently depended on three factors: appropriate patient selection, surgical expertise, and treatment within high-volume multidisciplinary centers. These principles were evident across thyroid, parathyroid, and adrenal surgery. Conclusions: Innovation in endocrine surgery derives its value not from technology itself, but from its appropriate application to individual patients. Although technological advances broaden surgical capabilities, clinical outcomes remain primarily determined by sound judgment, surgical expertise, and organization of care. Technology should therefore be regarded as an adjunct to, rather than a substitute for, high-quality clinical decision-making.